Nkure Therapeutics is an innovative biotechnology firm specializing in the development of Natural Killer (NK) cell therapies for cancer treatment. Their mission is to make cutting-edge and affordable immunotherapies accessible, with a focus on improving patient outcomes and extending Indian innovation globally.
April 27, 2023
Nkure raises pre-Series A round
The company is pioneering affordable NK cell therapy for the treatment of Cancer. Nkure is scaling rapidly from its first year of inception having successfully developed an NK cell platform at laboratory scale coupled with agreements with CDMOs in India and the US. It has also secured exclusive licenses to a specialized CAR and related technologies to enable allogenic cell therapy, the first of its kind in India.